<- Go home

Added to YB: 2025-11-26

Pitch date: 2025-11-24

TEM [neutral]

Tempus AI, Inc.

-37.77%

current return

Author Info

No bio for this author

Company Info

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician’s desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.

Market Cap

$8.4B

Pitch Price

$76.01

Price Target

88.00 (+86%)

Dividend

N/A

EV/EBITDA

-57.12

P/E

-33.40

EV/Sales

7.05

Sector

Life Sciences Tools and Services

Category

growth

Show full summary:
Tempus AI (TEM): Comprehensive Investment Analysis, Valuation, and Strategic Outlook

TEM: Precision medicine data flywheel creating AI-powered oncology monopoly. Q3 2025 hit +$1.5M adj EBITDA milestone, 140% NRR proves pharma data stickiness. Ambry acquisition adds germline testing scale. DCF fair value ~$88 vs $70-85 trading range. High SBC dilution risk but fortress $764M cash balance.

Read full article (16 min)